• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.09% Nasdaq Up 0.94%

    Mast Therapeutics, Inc. (MSTX)

    -NYSE MKT
    0.46 Down 0.00(0.73%) 2:42PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:0.47
    Open:0.47
    Bid:0.46 x 600
    Ask:0.46 x 900
    1y Target Est:2.38
    Beta:0.92
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:0.46 - 0.48
    52wk Range:0.40 - 0.69
    Volume:351,104
    Avg Vol (3m):890,260
    Market Cap:75.66M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MSTX

    Comparison

    Symbol% ChgMkt Cap
    MSTXDown 0.73%75.66M
    GSKUp 0.23%100.70B
    RHHBYUp 1.40%245.84B
    SNYUp 0.51%140.16B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.26
    Quarterly EPS Est (Jun-15) :-0.06
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cel... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback